AGL 40.20 Decreased By ▼ -1.30 (-3.13%)
AIRLINK 129.11 Increased By ▲ 1.11 (0.87%)
BOP 6.60 Increased By ▲ 0.34 (5.43%)
CNERGY 4.03 Decreased By ▼ -0.10 (-2.42%)
DCL 8.45 Increased By ▲ 0.01 (0.12%)
DFML 41.25 Increased By ▲ 0.56 (1.38%)
DGKC 87.00 Decreased By ▼ -0.90 (-1.02%)
FCCL 33.35 Decreased By ▼ -0.75 (-2.2%)
FFBL 65.90 Decreased By ▼ -0.43 (-0.65%)
FFL 10.54 Decreased By ▼ -0.02 (-0.19%)
HUBC 110.70 Increased By ▲ 2.00 (1.84%)
HUMNL 15.23 Increased By ▲ 0.77 (5.33%)
KEL 4.78 Increased By ▲ 0.13 (2.8%)
KOSM 7.83 Increased By ▲ 0.50 (6.82%)
MLCF 41.90 Decreased By ▼ -0.82 (-1.92%)
NBP 60.50 Decreased By ▼ -0.34 (-0.56%)
OGDC 182.80 Increased By ▲ 3.83 (2.14%)
PAEL 25.36 Decreased By ▼ -0.34 (-1.32%)
PIBTL 6.26 Increased By ▲ 0.20 (3.3%)
PPL 147.81 Increased By ▲ 1.66 (1.14%)
PRL 24.56 Decreased By ▼ -0.35 (-1.41%)
PTC 16.24 Increased By ▲ 0.10 (0.62%)
SEARL 70.50 Increased By ▲ 0.30 (0.43%)
TELE 7.30 Increased By ▲ 0.08 (1.11%)
TOMCL 36.30 Increased By ▲ 0.10 (0.28%)
TPLP 7.85 Increased By ▲ 0.01 (0.13%)
TREET 15.30 Decreased By ▼ -0.29 (-1.86%)
TRG 51.70 Increased By ▲ 1.34 (2.66%)
UNITY 27.35 Increased By ▲ 0.45 (1.67%)
WTL 1.23 Decreased By ▼ -0.01 (-0.81%)
BR100 9,842 Increased By 47.4 (0.48%)
BR30 30,036 Increased By 389.6 (1.31%)
KSE100 92,520 Increased By 499.1 (0.54%)
KSE30 28,786 Increased By 121.7 (0.42%)

AGP Limited, a Pakistani pharmaceutical company, has acquired a select portfolio of products from American firm Viatris Inc. through a Special Purpose Vehicle (SPV), a move authorised by AGP’s board last year.

The pharma shared the development in a notice to the Pakistan Stock Exchange (PSX) on Friday.

“We are pleased to inform you that after securing requisite approvals, AGP Limited, through a SPV- OBS Pakistan (Private) Limited, has successfully acquired a portfolio of certain pharmaceutical brands from Viatris Inc. which are commercialized in Pakistan primarily under the brands previously owned by Pfizer Inc.,” read the notice.

Viatris was formed in 2020 when pharma company Mylan merged with Upjohn, Pfizer’s off-patent medicine division.

AGP said that the portfolio it has acquired include a broad range of anti-depressants, anti- hypertensive and opthalmogoly products.

It said all the brands are well established with high brand equity and strong customer loyalty, including Zoloft, Cardura, Lyrica and Lipitor. The largest brand in the portfolio is Norvasc, which it said has recorded a turnover of Rs1.3 billion during the last 12 months as per a report issued by IQVIA Solutions Pakistan.

Pakistani pharma aims to acquire Sandoz owned brands to enhance share

The acquisition is expected to result in a significant increase in the consolidated revenues of AGP, which is expected to cross Rs20 billion over the next 12 months.

The company said it will also begin in-house manufacturing of the majority of these brands in due course, which will result in “economies of scale, operational synergies, and logistical efficiencies and in turn, maximizing shareholders’ value.”

AGP is a subsidiary of OBS Pakistan and the ultimate parent company is West End 16 Pte Limited- Singapore.

Last year in June, AGP said that its board has authorised it to acquire a select portfolio of products from Viatris Inc. through a SPV. The company had then said the SPV will acquire the brands through an optimal capital structure comprising equity and debt in the ratio of 25:75.

It also said AGP will own up to 85% shareholding in the SPV.

Comments

Comments are closed.